HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Previous close
$1.18
Day range
$1.13 - $1.21
Year range
$0.98 - $1.68
Market cap
32.52M USD
Avg Volume
72.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.22M | -54.56% |
Net income | -6.46M | 55.23% |
Net profit margin | — | — |
Earnings per share | -0.21 | 56.25% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.92M | -39.82% |
Total assets | 75.82M | -30.10% |
Total liabilities | 6.98M | -31.05% |
Total equity | 68.84M | — |
Shares outstanding | 27.33M | — |
Price to book | 0.47 | — |
Return on assets | -22.96% | — |
Return on capital | -25.38% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.46M | 55.23% |
Cash from operations | -7.60M | 47.17% |
Cash from investing | 5.83M | -64.56% |
Cash from financing | 0.00 | — |
Net change in cash | -1.76M | -185.02% |
Free cash flow | -5.65M | 37.10% |
About
Founded
2017
Headquarters
Website
Employees
22
